"CD36 Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Leukocyte differentiation antigens and major platelet membrane glycoproteins present on MONOCYTES; ENDOTHELIAL CELLS; PLATELETS; and mammary EPITHELIAL CELLS. They play major roles in CELL ADHESION; SIGNAL TRANSDUCTION; and regulation of angiogenesis. CD36 is a receptor for THROMBOSPONDINS and can act as a scavenger receptor that recognizes and transports oxidized LIPOPROTEINS and FATTY ACIDS.
| Descriptor ID |
D018955
|
| MeSH Number(s) |
D12.776.157.530.300.500 D12.776.395.550.625.136 D12.776.543.550.625.136 D12.776.543.585.300.500 D12.776.543.750.011 D12.776.543.750.705.675.136 D12.776.543.750.705.940.625.249 D12.776.543.750.710.450.750.625.249
|
| Concept/Terms |
CD36 Antigens- CD36 Antigens
- Antigens, CD36
- Thrombospondin Receptor
- Receptor, Thrombospondin
- Receptors, Thrombospondin
- Thrombospondin Receptors
- OKM5 Antigen
- Antigen, OKM5
- Platelet Glycoprotein IV
- Glycoprotein IV, Platelet
- Platelet Membrane Glycoprotein IIIb
- Platelet Glycoprotein IIIb
- Glycoprotein IIIb, Platelet
- SR-BI Protein
- SR BI Protein
- Adipocyte Membrane Protein p88
- CD36 Fatty Acid Transporter
- FAT (Fatty Acid Translocase) - CD36 Antigen
- CD36 Antigen (Collagen Type I Receptor, Thrombospondin Receptor)
- GPIV Platelet Glycoprotein
- Platelet Glycoprotein, GPIV
- GPIIIb Platelet Glycoprotein
- Platelet Glycoprotein, GPIIIb
- Scavenger Receptors, Class B, Type I
- SR-BI Receptor
- Receptor, SR-BI
- SR BI Receptor
- CD36 Protein
- CD36 Antigen
- Antigen, CD36
- Platelet Membrane Glycoprotein IV
|
Below are MeSH descriptors whose meaning is more general than "CD36 Antigens".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Carrier Proteins [D12.776.157]
- Membrane Transport Proteins [D12.776.157.530]
- Fatty Acid Transport Proteins [D12.776.157.530.300]
- CD36 Antigens [D12.776.157.530.300.500]
- Glycoproteins [D12.776.395]
- Membrane Glycoproteins [D12.776.395.550]
- Platelet Membrane Glycoproteins [D12.776.395.550.625]
- CD36 Antigens [D12.776.395.550.625.136]
- Membrane Proteins [D12.776.543]
- Membrane Glycoproteins [D12.776.543.550]
- Platelet Membrane Glycoproteins [D12.776.543.550.625]
- CD36 Antigens [D12.776.543.550.625.136]
- Membrane Transport Proteins [D12.776.543.585]
- Fatty Acid Transport Proteins [D12.776.543.585.300]
- CD36 Antigens [D12.776.543.585.300.500]
- Receptors, Cell Surface [D12.776.543.750]
- CD36 Antigens [D12.776.543.750.011]
- Receptors, Immunologic [D12.776.543.750.705]
- Platelet Membrane Glycoproteins [D12.776.543.750.705.675]
- CD36 Antigens [D12.776.543.750.705.675.136]
- Receptors, Scavenger [D12.776.543.750.705.940]
- Scavenger Receptors, Class B [D12.776.543.750.705.940.625]
- CD36 Antigens [D12.776.543.750.705.940.625.249]
- Receptors, Lipoprotein [D12.776.543.750.710]
- Receptors, LDL [D12.776.543.750.710.450]
- Receptors, Scavenger [D12.776.543.750.710.450.750]
- Scavenger Receptors, Class B [D12.776.543.750.710.450.750.625]
- CD36 Antigens [D12.776.543.750.710.450.750.625.249]
Below are MeSH descriptors whose meaning is more specific than "CD36 Antigens".
This graph shows the total number of publications written about "CD36 Antigens" by people in this website by year, and whether "CD36 Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD36 Antigens" by people in Profiles.
-
Rodriguez A, Yu M, Phoo MT, Holinstat M, Schwendeman A. Antiplatelet Effects of DMPC-Based Synthetic High-Density Lipoproteins: Exploring Particle Structure and Noncholesterol Efflux Mechanisms. Mol Pharm. 2025 03 03; 22(3):1305-1317.
-
Madan N, Ghazi AR, Kong X, Chen ES, Shaw CA, Edelstein LC. Functionalization of CD36 cardiovascular disease and expression associated variants by interdisciplinary high throughput analysis. PLoS Genet. 2019 07; 15(7):e1008287.
-
Hou X, Summer R, Chen Z, Tian Y, Ma J, Cui J, Hao X, Guo L, Xu H, Wang H, Liu H. Lipid Uptake by Alveolar Macrophages Drives Fibrotic Responses to Silica Dust. Sci Rep. 2019 01 23; 9(1):399.
-
Danilo C, Gutierrez-Pajares JL, Mainieri MA, Mercier I, Lisanti MP, Frank PG. Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development. Breast Cancer Res. 2013; 15(5):R87.
-
Murphy-Ullrich JE, Iozzo RV. Thrombospondins in physiology and disease: new tricks for old dogs. Matrix Biol. 2012 Apr; 31(3):152-4.
-
Bhavanasi D, Kim S, Goldfinger LE, Kunapuli SP. Protein kinase Cd mediates the activation of protein kinase D2 in platelets. Biochem Pharmacol. 2011 Oct 01; 82(7):720-7.
-
Baker AD, Malur A, Barna BP, Kavuru MS, Malur AG, Thomassen MJ. PPARgamma regulates the expression of cholesterol metabolism genes in alveolar macrophages. Biochem Biophys Res Commun. 2010 Mar 19; 393(4):682-7.
-
Augustus AS, Buchanan J, Gutman E, Rengo G, Pestell RG, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP. Hearts lacking caveolin-1 develop hypertrophy with normal cardiac substrate metabolism. Cell Cycle. 2008 Aug 15; 7(16):2509-18.
-
Salajegheh M, Raju R, Schmidt J, Dalakas MC. Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis. J Neuroimmunol. 2007 Jul; 187(1-2):166-74.
-
Huang LT, Paredes CJ, Papoutsakis ET, Miller WM. Gene expression analysis illuminates the transcriptional programs underlying the functional activity of ex vivo-expanded granulocytes. Physiol Genomics. 2007 Sep 19; 31(1):114-25.